BOC Sciences - Products
London
BOC Sciences provides various research (bio)chemicals: inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities, metabolites, APIs, natural compounds, ADCs, and chiral compounds.
| Product | Description | |
|---|---|---|
| Caulophylline B | Caulophylline B is an alkaloid isolated from the roots of Caulophyllum robustum Maxim. Group: Pharmaceutical. CAS No. 1359978-55-4. Pack Sizes: 2 mg. Product ID: NP0846. Molecular formula: Custom synthesis is available. Send your inquiries for more information. |  London |
| Cavaol E | Cavaol E is a natural compound commonly found in plants with potential biomedical applications. Studies have shown that Cavaol E exhibits antioxidant and anti-inflammatory properties, making it a promising candidate for studying oxidative stress-related diseases such as cancer and cardiovascular disorders. Group: Pharmaceutical. CAS No. 1233044-20-6. Pack Sizes: 1 mg. Product ID: NP5007. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| CAY10499 | Monoglyceride lipase (MGL) plays an important role in the metabolism of the lipid transmitter 2-arachidonoylglycerol (2-AG). CAY10499 is a potent and selective monoglyceride lipase (MGL) inhibitor exhibiting an IC50 of 90 nM for the recombinant enzyme. It is also a non-selective lipase inhibitor (IC50s = 144, 90, and 14 nM for human recombinant MAGL, HSL, and FAAH, respectively). CAY10499 inhibits the growth of MCF-7, MDA-MB-231, COV318, and OVCAR-3 cancer cells (IC50s = 4.2, 46, 106.7, and 79.8 mM, respectively). Group: Pharmaceutical. CAS No. 359714-55-9. Pack Sizes: 100 mg. Product ID: B1370-292092. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| CB-839 | CB-839 an is orally bioavailable inhibitor of glutaminase, with potential antineoplastic activity. Upon oral administration, CB-839 selectively and irreversibly inhibits glutaminase, a mitochondrial enzyme that is essential for the conversion of the amino acid glutamine into glutamate. By blocking glutamine utilization, proliferation in rapidly growing cells is impaired. Glutamine-dependent tumors rely on the conversion of exogenous glutamine into glutamate and glutamate metabolites to both provide energy and generate building blocks for the production of macromolecules, which are needed for cellular growth and survival. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus). ( ). Group: Pharmaceutical. CAS No. 1439399-58-2. Pack Sizes: 20 mg. Product ID: B0084-462472. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| CBL0137 | CBL0137 is a metabolically stable curaxin that activates p53 with an EC50 value of 0.37 μM and inhibits NF-κB with an EC50 of 0.47 μM. It also inhibits histone chaperone FACT (facilitates chromatin transcription) and MYC signal. Group: Pharmaceutical. CAS No. 1197996-80-7. Pack Sizes: 2.5 mg. Product ID: B0084-284751. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| CBL0137 hydrochloride | NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) is a protein complex that controls transcription of DNA, cytokine production and cell survival. CBL0137 activates p53 and inhibits NF-kB with EC50s of 0.37 μM and 0.47 μM in the cell-based p53 and NF-kB reporter assays, respectively. It functionally inactivates the facilitates chromatin transcription complex, driving the effects on p53 and NF-κB and promoting cancer cell death. Group: Pharmaceutical. CAS No. 1197397-89-9. Pack Sizes: 50 mg. Product ID: B2693-292244. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| CBS9106 | CBS9106, also known as BMS-566419, is a novel reversible oral CRM1 inhibitor with CRM1 degrading activity. CRM1 plays an important role in the nuclear export of cargo proteins bearing nuclear exporting signal sequences. CBS9106 inhibits CRM1-dependent nuclear export, causing arrest of the cell cycle and inducing apoptosis in a time- and dose-dependent manner for a broad spectrum of cancer cells, including multiple myeloma cells. CBS9106 reduces CRM1 protein levels significantly without affecting CRM1 mRNA expression. Oral administration of CBS9106 significantly suppresses tumor growth and prolongs survival in mice bearing tumor xenograft without a significant loss in body weight. A reduced level of CRM1 protein is also observed in tumor xenografts isolated from mice treated with CBS9106. Taken together, these results indicate that CBS9106 is a novel reversible CRM1 inhibitor and a promising clinical candidate. Group: Pharmaceutical. CAS No. 1076235-04-5. Pack Sizes: 10 mg. Product ID: B1370-462313. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| CC122 | CC122 is a novel agent for DLBCL. It is an orally available pleiotropic pathway modulator. It has antitumor and immunomodulatory activity. It is used for the treatment of chronic lymphocytic leukemia. It binds CRBN and degrades Aiolos and Ikaros resulting in a mimicry of IFN signaling and apoptosis in DLBCL. It inhibits proliferation and induces apoptosis in ABC and GCB DLBCL in vitro. It was developed by Celgene Corporation(CELG) and was in clinic phase 2 trial. Uses: Cc122 has antitumor and immunomodulatory activity. it is used for the treatment of chronic lymphocytic leukemia. Group: Pharmaceutical. CAS No. 1015474-32-4. Pack Sizes: 25 mg. Product ID: B0084-474963. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| CC-17368 | CC-17368 is a hydroxyisoindole derivative and metabolite of pomalidomide that has potential activity in anticancer study like multiple myeloma. Group: Pharmaceutical. CAS No. 1547162-41-3. Pack Sizes: 100 mg. Product ID: B2694-475859. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| CC-223 | CC-223, a mTOR kinase inhibitor, has been found to be effective in inducing the apoptosis and reducing the proliferation of tumor cells. It is still under Phase I/II clinical trial by Celgene Corporation. IC50: 16 nM. Uses: Cc-223 is a mtor kinase inhibitor that has been found to be effective in inducing the apoptosis and reducing the proliferation of tumor cells. Group: Pharmaceutical. CAS No. 1228013-30-6. Pack Sizes: 300 mg. Product ID: B0084-474093. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| CC-885 | CC-885 is a cereblon (CRBN) modulator with an anti-tumour activity mediated through the cereblon-dependent ubiquitination and degradation of the translation termination factor GSPT1. CC-885 potently suppresses the proliferation of human acute myeloid leukaemia (AML) tumour cell lines. Uses: Antitumor agent. Group: Pharmaceutical. CAS No. 1010100-07-8. Pack Sizes: 100 mg. Product ID: B2693-054699. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| CCG 50014 | CCG 50014 is a potent and selective inhibitor of RGS4 with IC50 of 30 nM, exhibiting >20-fold selectivity over other RGS proteins. Group: Pharmaceutical. CAS No. 883050-24-6. Pack Sizes: 25 mg. Product ID: B2693-463473. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| CCK Octapeptide (non-sulfated) | Cholecystokinin (CCK) is a neuropeptide and gut hormone that regulates pancreatic enzyme secretion and gastrointestinal motility, and acts as a satiety signal. CCK Octapeptide (non-sulfated) is the non-sulfated form of the C-terminal octapeptide of CCK. Group: Pharmaceutical. CAS No. 25679-24-7. Pack Sizes: 5 mg. Product ID: BAT-006185. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| CDDO Imidazolide | CDDO Imidozolide is a synthetic triterpenoid as a Nrf2 signaling activator with highly active in suppressing cellular proliferation of human leukemia and breast cancer cell. Uses: Nrf2 signaling activator. Group: Pharmaceutical. CAS No. 443104-02-7. Pack Sizes: 10 mg. Product ID: B2693-474173. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cebranopadol | Cebranopadol is a novel first-in-class compound with potent agonist activity on opioid receptor like-1(ORL-1) and the well established mu opioid receptor. It showed antinociceptive and antihypertensive effects in a variety of different animal models of pain, suggesting its potential use for the treatment of chronic pain states. Group: Pharmaceutical. CAS No. 863513-91-1. Pack Sizes: 10 mg. Product ID: B0084-474871. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cediranib dihydrochloride | Cediranib (AZD-2171; tentative trade name Recentin) is a potent inhibitor of vascular endothelial growth factor (VEGF) receptor tyrosine kinases.The drug is being developed by AstraZeneca as a possible anti-cancer chemotherapeutic agent for oral administration. Group: Pharmaceutical. CAS No. 288383-20-0. Pack Sizes: 50 mg. Product ID: B2693-065171. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cediranib maleate | Cediranib maleate is a highly potent VEGFR(KDR) inhibitor with IC50 of <1 nM. It also inhibits Flt1/4 with IC50 of 5 nM/≤3 nM. It inhibits VEGF-stimulated proliferation with IC50 of 0.4 nM in vitro. It suppresses PDGF-AA with IC50 of 0.04 μM in MG63 cell lines. It even suppresses tubule sprouting at subnanomolar concentrations and inhibits VEGF-induced angiogenesis in vivo. It causes hypertrophy in bone growth plate and prevents luteal development in ovary. It shows broad spectrum activity in human tumor models at doses that are well tolerated. It causes regression of vascular tissues in human lung tumor xenografts. Group: Pharmaceutical. CAS No. 857036-77-2. Pack Sizes: 100 mg. Product ID: B2693-459903. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cefaclor Impurities | Cefaclor Impurities occupy a crucial role within the biomedical sector, integral for assessing the quality and refinement of cefaclor. This antibiotic, pivotal against bacterial afflictions like pneumonia and dermal infections, benefits from impurity analysis, ensuring pharmaceutical integrity by detecting degradation and contaminants throughout manufacturing. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cefadroxil Impurities | Cefadroxil Impurities, instrumental in pharmaceutical research, are crucial to the synthesis and stringent quality control of cefadroxil, a versatile antibiotic combating bacterial infections like tonsillitis, skin disorders, and urinary tract issues. These impurities significantly aid in assessing the drug's safety and therapeutic effectiveness, ensuring its optimal clinical application. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cefalonium Impurities | Cefalonium Impurities are integral to pharmaceutical quality assurance, especially in antibiotic development and production. These impurities are vital in safeguarding cefalonium's safety and efficacy, a key antibiotic in veterinary medicine, primarily targeting bacterial infections like bovine mastitis, thereby ensuring the health of livestock through precise contaminant control. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cefamandole Impurities | Cefamandole Impurities, embodying residual constituents within cefamandole structures, hold profound importance in pharmaceutical R&D. Their examination aids in enhancing cefamandole's purity and safety, a crucial broad-spectrum antibiotic, thereby augmenting its efficacy and stability in combating bacterial pathogens affecting respiratory and urinary systems, critical for therapeutic advancements. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cefapirin Sodium Impurities | Cefapirin Sodium Impurities hold pivotal importance in biomedical research, facilitating the critical assessment of cefapirin antibiotics' safety and efficacy. These impurities play an essential role in the thorough analysis and refinement of pharmaceutical compositions aimed at combating bacterial infections, thereby ensuring optimal therapeutic performance and safety in addressing bacterial ailments. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cefathiamidine Impurities | Cefathiamidine Impurities are crucial in the quality control and pharmacokinetic studies of Cefathiamidine, an antibiotic used to treat bacterial infections. Identifying and quantifying these impurities ensure drug safety and efficacy by understanding metabolism and stability profiles in pharmaceutical applications. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cefazedone Impurities | Cefazedone Impurities are crucial in the pharmaceutical industry, primarily for quality control during Cefazedone synthesis. These impurities help identify and quantify unwanted byproducts, ensuring the efficacy and safety of Cefazedone, an antibiotic commonly used to treat various bacterial infections, including respiratory and skin infections. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cefazolin EP Impurity G | An impurity of Cefazolin, an antibiotic used for the treatment of bacterial infections. Group: Pharmaceutical. CAS No. 1172998-53-6. Pack Sizes: 10 mg. Product ID: B2694-341911. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cefazolin Impurities | Cefazolin Impurities hold a fundamental role in pharmaceutical endeavors, crucial for the refinement and validation of analytical methodologies aimed at ensuring cefazolin's quality, efficacy, and safety. By elucidating degradation pathways, these impurities profoundly enhance comprehension of cefazolin's pharmacological characteristics, thereby aiding its efficacious application in the treatment of bacterial infections. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cefazolin Impurity C | an impurity of Cefazolin. Group: Pharmaceutical. CAS No. 56842-77-4. Pack Sizes: 50 mg. Product ID: B0547-468329. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cefazolin Impurity D | An impurity of Cefazolin, an antibiotic used for the treatment of bacterial infections. Group: Pharmaceutical. CAS No. 32510-61-5. Pack Sizes: 50 mg. Product ID: B2694-468328. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cefdinir Impurities | Cefdinir Impurities, found during cefdinir synthesis, are significant in the development and assurance of antibiotic quality. These impurities assist in understanding degradation pathways and enhancing drug formulation, ensuring efficacy in treating bacterial infections such as respiratory tract infections. They are pivotal in quality control and pharmaceutical research. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cefditoren Impurities | Cefditoren Impurities are integral to biomedical research, underpinning the exploration of cefditoren pivoxil's intricacies. These entities are paramount in ensuring the antibiotic's quality, safety, and efficacy. As a cornerstone of cephalosporin antibiotics, they are extensively applied in addressing infections such as bronchitis, pneumonia, and dermatological conditions. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cefepime hydrochloride hydrate | Cefepime is an extended-spectrum parenteral cephalosporin antibiotic active in vitro against a broad spectrum of gram-positive and gram-negative aerobic bacteria. Cefepime dosing was 1-4 g/day (0.5-2.0 g twice daily) for adults; ceftazidime dosing was 1-6 g/day (0.5 g every 12 hours to 2.0 g every 8 hours). A limited number of cefepime-treated patients received 2 g every 8 hours. The median length of dosing for both cefepime and ceftazidime was 7 days. Cefepime has a decreased propensity to induce beta-lactamases compared with other beta-lactam antibiotics. Cefepime has a pharmacokinetic disposition similar to that of other renally eliminated cephalosporins, with a half-life of approximately 2 hours. Cefepime has demonstrated clinical efficacy against a variety of infections, including urinary tract infections, pneumonia, and skin structure infections. Cefepime is generally well tolerated. Group: Pharmaceutical. CAS No. 123171-59-5. Pack Sizes: 5 g. Product ID: BBF-03810. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cefepime Impurities | Cefepime impurities, emerging throughout drug synthesis, are indispensable elements in the realm of biomedical quality assurance. These impurities play a central role in validating the safety and potency of cefepime, a fourth-generation cephalosporin. Their presence is pivotal for treating severe bacterial infections such as pneumonia and urinary tract afflictions, consequently refining pharmaceutical formulations. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cefetamet Impurities | Cefetamet Impurities, integral to pharmaceutical inquiry, underpin the evaluation of cefetamets purity, potency, and safety profile. As an antibiotic, cefetamet targets bacterial infections such as respiratory and urinary tract maladies. These impurities ensure rigorous quality control and formulation stability, bolstering the trustworthiness of cefetamet applications. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cefiderocol | This active molecular is a potent cephalosporin antibiotic with a catechol moiety on the 3-position side chain under the development of Shionogi. Cefiderocol exhibits potent activity against the non-fermenting Gram-negative bacteria in vitro including Acinetobacter baumannii, Pseudomonas aeruginosa and Stenotrophomonas maltophilia. Now Cefiderocol is in clinical Phase III for treatment of severe infections caused by Carbapenem-resistant Gram-negative pathogens. Uses: Gram-negative infections. Group: Pharmaceutical. CAS No. 1225208-94-5. Pack Sizes: 1 mg. Product ID: B0084-475177. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cefixime Impurities | Cefixime Impurities hold a critical position within pharmaceutical sciences, serving as essential analytes for assessing Cefixime's stability and purity. This robust antibiotic targets diverse bacterial infections, including urinary tract disease, otitis media, and pharyngitis. Impurities are pivotal in guaranteeing drug quality, regulatory adherence, and integrity through developmental stages. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cefmetazole Impurities | Cefmetazole Impurities are key reference materials critical for ensuring the quality and efficacy of cefmetazole, an antibiotic used in treating bacterial infections, including skin, urinary tract, and respiratory infections. These impurities facilitate thorough analysis and assessment during drug formulation and regulatory compliance in the pharmaceutical industry. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cefminox Impurities | Cefminox Impurities constitute an essential component in the stringent quality assurance and developmental scrutiny of cefminox, an antibiotic pivotal in addressing bacterial afflictions like respiratory and urinary infections. Their comprehensive analysis fortifies drug efficacy and safety, fostering exploration into potential analog creation and stability across varied environmental conditions. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cefodizime Impurities | Cefodizime Impurities are critical in the biomedical industry for ensuring the purity and efficacy of cefodizime, a third-generation cephalosporin antibiotic. They help in the analysis and quality control during the drug development process, targeting bacterial infections, including respiratory and urinary tract ailments. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cefoperazone Impurities | Cefoperazone Impurities, indispensable in quality assurance and research, maintain the sanctity of cefoperazone, a third-generation cephalosporin. Integral to verifying drug purity and efficacy, these impurities are crucial in combating bacterial infections such as respiratory and urinary tract ailments, including peritonitis, thereby fortifying pharmaceutical integrity and therapeutic success. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cefoperazone Impurity A | Cefoperazone impurity. Group: Pharmaceutical. CAS No. 73240-08-1. Pack Sizes: 10 mg. Product ID: B2694-468448. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cefotaxime Impurities | Cefotaxime Impurities are key components in pharmaceutical quality control, ensuring the purity and efficacy of Cefotaxime, an antibiotic essential in treating bacterial infections such as meningitis and septicemia. Their analysis aids in identifying contamination levels, optimizing drug formulations, and safeguarding therapeutic outcomes in clinical applications. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cefotiam Impurities | Cefotiam Impurities hold paramount importance within the pharmaceutical realm, serving as essential components for quality assurance and safety evaluations of cefotiam, a cephalosporin antibiotic. These elements are crucial in maintaining drug efficacy and purity, notably in combating respiratory and urinary tract infections, aiding in enhanced synthesis and adherence to regulatory standards. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cefovecin sodium | Cefovecin Sodium is an antibiotic of the cephalosporin class. It is used for the treatment of skin infections caused by Pasturella multocida in cats, and Staphylococcus intermedius/S. canis in dogs. Cefovecin Sodium is the first single-dose injectable antibiotic for dogs and cats. Uses: The treatment of skin conditions in dogs and cats. Group: Pharmaceutical. CAS No. 141195-77-9. Pack Sizes: 50 mg. Product ID: B2692-423908. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cefoxitin Impurities | Cefoxitin Impurities serve an essential function in pharmaceutical quality assurance, specifically for Cefoxitin, a vital beta-lactam antibiotic. These impurities assist in assessing the compound's purity and stability, thereby guaranteeing its effective application in treating bacterial infections such as those affecting respiratory and urinary systems. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cefozopran hydrochloride | Cefozopran hydrochloride is a fourth-generation cephalosporin produced by Cephalosporium. Group: Pharmaceutical. CAS No. 113981-44-5. Pack Sizes: 100 mg. Product ID: BBF-03862. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cefpirome sulfate | Cefpirome Sulfate is a fourth generation cephalosporin antibiotic. It was developed by German company Hoechst and France Roussel company together. Uses: Beta lactam antibiotics. Group: Pharmaceutical. CAS No. 98753-19-6. Pack Sizes: 5 g. Product ID: BBF-03973. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cefpodoxime | Cefpodoxime is a third-generation cephalosporin antibiotic. It is active against most gram-positive and gram-negative organisms. Group: Pharmaceutical. CAS No. 80210-62-4. Pack Sizes: 150 mg. Product ID: BBF-03948. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cefprozil Impurities | Cefprozil Impurities are critical in the pharmaceutical industry for ensuring the safety and efficacy of cefprozil, an antibiotic used in treating bacterial infections such as acute otitis media, pharyngitis, and skin structure infections. Understanding these impurities aids in refining drug formulation and enhancing therapeutic outcomes. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cefprozil Monohydrate EP Impurity E | An impurity of Cefprozil, a cephalosporin antibiotic used to treat a variety of bacterial infections. Group: Pharmaceutical. Pack Sizes: 1 mg. Product ID: B1370-049289. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cefprozil Monohydrate EP Impurity G | An impurity of Cefprozil, a cephalosporin antibiotic used to treat a variety of bacterial infections. Group: Pharmaceutical. Pack Sizes: 10 mg. Product ID: B1370-069753. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cefprozil Monohydrate EP Impurity I | An impurity of Cefprozil, a cephalosporin antibiotic used to treat a variety of bacterial infections. Group: Pharmaceutical. Pack Sizes: 10 mg. Product ID: B1370-084459. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cefradine Impurities | Cefradine Impurities, integral to the quality assurance protocols in cefradine antibiotic fabrication, play a crucial role in validating drug purity and potency. Their monitoring is vital in pinpointing degradation by-products, thereby safeguarding the therapeutic integrity and safety of cefradine employed in bacterial infection treatments. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cefroxadine | It is produced by the strain of Semisynthetic first generation oral cephalosporin. Cefroxadine (CXD), an orally active cephalosporin antibiotic, has a broad spectrum and a bactericidal action. CXD showed excellent results in the treatment of acute uncomplicated cystitis (AUC). Group: Pharmaceutical. CAS No. 51762-05-1. Pack Sizes: 100 mg. Product ID: BBF-00741. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cefsulodin sodium | Cefsulodin is a third generation cephalosporin antibiotic designed specifically for Pseudomonas Aeruginosa. Uses: Anti-bacterial agents. Group: Pharmaceutical. CAS No. 52152-93-9. Pack Sizes: 5 g. Product ID: BBF-03891. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ceftaroline fosamil acetate hydrate | Ceftaroline fosamil acetate hydrate is the salt of Ceftaroline fosamil, which is an antibiotic indicated for bacterial skin infections. It is effective against MRSA and other Gram-positive bacteria. Group: Pharmaceutical. CAS No. 866021-48-9. Pack Sizes: 500 mg. Product ID: B2692-059200. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ceftazidime Impurities | Ceftazidime Impurities are crucial in the biomedical sector for ensuring the quality and safety of the antibiotic ceftazidime. Monitoring these impurities aids in maintaining efficacy against bacterial infections, particularly Pseudomonas aeruginosa, and helps in compliance with pharmaceutical regulations, thereby safeguarding patient health during treatment. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ceftazidime Impurity A | An impurity of Ceftazidime, an antibiotic for certain infection treatment. Group: Pharmaceutical. CAS No. 1000980-60-8. Pack Sizes: 1 mg. Product ID: B2694-468514. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ceftazidime Impurity G | An impurity of ceftazidime, an antibiotic used for certain infection treatment. Group: Pharmaceutical. CAS No. 194241-83-3. Pack Sizes: 1 mg. Product ID: B2694-468518. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ceftazidime Impurity H | An impurity of ceftazidime, an antibiotic used for certain infection treatment. Group: Pharmaceutical. CAS No. 1354396-23-8. Pack Sizes: 1 mg. Product ID: B2694-468519. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ceftazidime Intermediate | An impurity of ceftazidime, an antibiotic used for certain infection treatment. Group: Pharmaceutical. CAS No. 158183-05-2. Pack Sizes: 10 mg. Product ID: B2694-468520. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cefteram Impurities | Cefteram Impurities are critical in the pharmaceutical industry for ensuring the purity and efficacy of the antibiotic cefteram. These impurities are essential for analytical studies and quality control processes, aiding in the development of treatments for bacterial infections, particularly those caused by Gram-positive and Gram-negative bacteria. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cefteram pivoxil | It is produced by the strain of Semisynthetic third generation cephalosporin. Ceftrium Pivoxil is a prevalent of ceftrium, which is a semi-synthetic, broad-spectrum antibiotic with antibacterial activity. Uses: Anti-bacterial agents. Group: Pharmaceutical. CAS No. 82547-81-7. Pack Sizes: 100 mg. Product ID: BBF-00745. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ceftezole Impurities | Ceftezole Impurities are crucial in the biomedical field for quality control during ceftezole antibiotic production. These impurities are essential for the development of analytical methods to ensure drug purity and efficacy in treating bacterial infections. Their study aids in understanding drug stability and safety profiles. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ceftibuten Dihydrate | Dihydrate form of Ceftibuten which is one of the third-generation cephalosporin antibiotics. Uses: Dihydrate form of ceftibuten which is one of the third-generation cephalosporin antibiotics. Group: Pharmaceutical. CAS No. 118081-34-8. Pack Sizes: 100 mg. Product ID: B0084-055292. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ceftibuten Impurities | Ceftibuten Impurities, integral to the biomedical sector, play a critical role in safeguarding and validating ceftibuten's antibiotic potency against bacterial pathogens. Vigilant monitoring upholds drug quality, assures regulatory adherence, and fosters the innovation of ceftibuten formulations, ultimately enhancing therapeutic efficacy and patient care in antimicrobial therapies. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ceftiofur Impurities | Ceftiofur Impurities, integral to the biomedical realm, are scrutinized to assess the purity and safety of ceftiofur formulations. These impurities are vital to guarantee ceftiofur's efficacy, a pivotal cephalosporin antibiotic combating livestock bacterial infections, thereby ensuring animal health preservation and mitigating drug resistance emergence. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ceftizoxime Impurities | Ceftizoxime Impurities are pivotal in the biomedical sector, primarily utilized for analytical purposes in drug development and quality control. These impurities aid in understanding the pharmacokinetics and stability of Ceftizoxime, an antibiotic used to combat bacterial infections, ensuring safety and efficacy of therapeutic formulations. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ceftobiprole | Ceftobiprole is a cephalosporin prodrug with potent bactericidal activity against methicillin-resistant MRSA and penicillin-resistant Streptococcus pneumoniae (PRSP). Group: Pharmaceutical. CAS No. 209467-52-7. Pack Sizes: 5 mg. Product ID: B2692-062749. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ceftobiprole medocaril sodium | Ceftobiprole medocaril sodium is a water-soluble prodrug ceftobiprole, a 5th-generation cephalosporin for the treatment of hospital-acquired pneumonia (excluding ventilator-associated pneumonia) and community-acquired pneumonia. Ceftobiprole binds to penicillin-binding proteins (PBPs) and inhibits their transpeptidase activity. Group: Pharmaceutical. CAS No. 252188-71-9. Pack Sizes: 10 mg. Product ID: B2692-292584. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ceftriaxone EP Impurity B | An impurity of Cefotaxime sodium. It is also a degradation product for other cephalosporin antibiotics such as: Ceftriaxone , Cefodizime and Ceftiofur. Group: Pharmaceutical. CAS No. 66340-33-8. Pack Sizes: 10 mg. Product ID: B2694-468462. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
Would you like to list your products on UK Chemical Suppliers?
Our database is helping our users find suppliers everyday.